Integral Diagnostics Capitol Health Merger 2024 Investor Presentation

Integral Diagnostics and Capitol Health announced a transformative merger to create a leading ANZ diagnostic imaging company with combined FY23 revenues of $651 million. The transaction values Capitol at $351 million equity value with an 8.1x EV/FY25F EBITDA multiple including anticipated annual synergies of $10 million, expected to complete in Q4 2024.